Profound Medical Partners with Getz Healthcare for Advanced Prostate Care
Profound Medical Corp. (NASDAQ: PROF; TSX: PRN), a pioneering company in the medical device sector, is set to expand the reach of its ground-breaking TULSA-PRO system through a newly forged exclusive distribution agreement with Getz Healthcare. This strategic partnership aims to introduce the transformative TULSA Procedure to Australia and New Zealand, regions that are increasingly recognizing the benefits of innovative medical technologies.
The Innovative TULSA-PRO System
The TULSA-PRO system marks a significant breakthrough in the field of prostate care, offering a non-invasive treatment option that replaces traditional surgical and radiation methods. By utilizing an MRI suite, this advanced system employs precise, robotically controlled ultrasound technology to ablate unwanted prostate tissue while ensuring the surrounding structures remain unharmed. This level of precision is made possible through real-time MRI thermography and AI-driven temperature control, enabling physicians to tailor treatments meticulously to meet the needs of individual patients.
Main Advantages of the TULSA Procedure
One of the standout features of the TULSA Procedure is the ability to monitor and modify the treatment as it occurs. This not only promotes a more personalized medical approach but also significantly elevates patient safety and comfort compared to traditional therapies.
“Our exclusive partnership with Profound Medical is a major leap in advancing precise prostate care across Australia and New Zealand,” stated Derek Foltin, the Managing Director of Getz Healthcare ANZ. This partnership underscores Getz Healthcare’s commitment to delivering clinically validated technologies that aim to enhance patient outcomes, particularly in the rapidly evolving arena of prostate therapy.
Market Growth and Demand for Innovative Solutions
Prostate cancer's incidence rates continue to rise, with it being the most commonly diagnosed cancer among men in Australasia. Profound Medical's CEO and Chairman, Arun Menawat, expressed enthusiasm about tapping into this crucial market, stating that they are also exploring other strategic partnerships throughout the Asia Pacific region. This approach reflects their intent to broaden their influence and bring state-of-the-art healthcare solutions to an even wider audience.
About Getz Healthcare and Its Commitment
Getz Healthcare stands out as a frontrunner in distributing advanced medical devices and solutions across the Asia Pacific. With a history spanning over 110 years, they boast a robust operational network that serves thousands of healthcare providers. Their dedication to partnering with leading manufacturers ensures that they deliver innovative, high-quality products that help healthcare professionals offer enhanced care.
As an ISO 9001:2015 certified organization, Getz Healthcare’s mission centers on providing meaningful healthcare solutions and continuing to be an essential player in advancing medical technology within the region.
Profound Medical's Commitment to Advancing Healthcare
Profound Medical is committed to revolutionizing prostate cancer treatment through the development of AI-powered, MRI-guided therapies. The TULSA-PRO system not only offers a cutting-edge treatment option but is poised to become a leading modality in addressing a range of prostate conditions, from low-risk to high-risk cancer scenarios, as well as benign prostatic hyperplasia (BPH).
Further enhancing their treatment portfolio, Profound is also advancing the Sonalleve platform to tackle other health issues, illustrating their dedication to improving patient lives across multiple medical challenges.
Frequently Asked Questions
What is the TULSA-PRO system?
The TULSA-PRO system is a non-invasive medical device that utilizes MRI-guided robotic ultrasound technology to treat prostate issues efficaciously.
How does the TULSA Procedure compare to traditional treatments?
The TULSA Procedure offers a less invasive option compared to surgery and radiation, with real-time monitoring and precise tissue ablation.
Who is partnered with Profound Medical for the TULSA-PRO distribution?
Getz Healthcare is the exclusive distributor for the TULSA-PRO system in Australia and New Zealand.
What are Prospects for TULSA-PRO in the Asia Pacific region?
Profound Medical is actively looking to expand its strategic partnerships beyond Australia and New Zealand into other countries in the Asia Pacific region.
How does Profound Medical ensure the quality of its products?
Profound Medical centers its innovative solutions around rigorous clinical testing and adherence to regulatory standards ensuring efficacy and safety for patients.
